The global Multiplexed Diagnostics market garnered revenue around USD 8.6 Billion in 2019 and projected to reach USD 39.7 Billion in 2027, with at a compound annual growth rate (CAGR) 17.9% throughout the estimate period from 2020 to 2027.
Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively, in biochemical substances, cells of an organism, or an organic sample for disease diagnosis
Multiplexed diagnostics screen multiple analytes in a single cycle of assay procedure. Though single plex assays are widely available in the market, they fail to yield results for multiple analytes in a single cycle of assay process, and thus when multiple analytes are needed to be screened, cost and turnaround time of single plex assay is higher as compared to multiplexed assay.
Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases is the major factor to drive the global market.
North America dominated the global multiplexed diagnostics market in 2019 and anticipated to dominate during the forecast period.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Multiplexed Diagnostics market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Multiplexed Diagnostics market growth.
The global Multiplexed Diagnostics market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Key players include Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Luminex Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., Abbott Laboratories, among others
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
- Global Multiplexed diagnostics Market, by Technology
- Very High Density Multiplexed Assays
- High Density Multiplexed Assays
- Medium Density Multiplexed Assays
- Low Density Multiplexed Assays
- Next Generation Sequencing
- Global Multiplexed diagnostics Market, by Application
- Infectious disease diagnosis
- Oncology
- Autoimmune diseases
- Cardiac Diseases
- Allergies
- Others
- Global Multiplexed diagnostics Market, by End-user
- Academic Research Institutes
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical Companies
- Clinical Research Organizations
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
- North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Rest of EU
- Asia Pacific
- China
- India
- Japan
- Southeast Asia
- Rest of APAC
- Central & South America
- Brazil
- Argentina
- Rest of Central & South America
- Middle East and Africa
- UAE
- Saudi Arabia
- Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization